We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Post-Infection Zika Virus Shed in Saliva and Semen

By LabMedica International staff writers
Posted on 19 Oct 2016
Print article
Image: Digitally colorized transmission electron micrograph (TEM) of Zika virus. Virus particles, colored red, are 40 nanometers in diameter, with an outer envelope, and an inner dense core (Photo courtesy of the CDC).
Image: Digitally colorized transmission electron micrograph (TEM) of Zika virus. Virus particles, colored red, are 40 nanometers in diameter, with an outer envelope, and an inner dense core (Photo courtesy of the CDC).
Results of a study of the mechanism of Zika virus infection in two primate models demonstrated that the virus spread rapidly into the nervous system of healthy animals and that shedding of the virus in saliva and semen underscored possible concern for additional neurological complications and non-mosquito-mediated transmission in humans.

Infection with Zika virus has been associated with serious neurological complications and fetal abnormalities. However, the dynamics of viral infection, replication and shedding are poorly understood.

To obtain a better understanding of the mechanism that underlies Zika virus infection, investigators at Beth Israel Deaconess Medical Center (Boston, MA, USA) colleagues infected 36 rhesus and cynomolgus macaques with subcutaneous injections of strains of the Zika virus from Puerto Rico and Thailand. Over the next four weeks, the investigators analyzed blood, tissues, cerebrospinal fluid (CSF), and mucosal secretions for the presence of Zika virus RNA and monitored the animals' immune response during early infection.

They reported in the October 3, 2016, online edition of the journal Nature Medicine that viral RNA could be detected in blood plasma as early as one day after infection. Viral RNA was also detected in saliva, urine, CSF, and semen, but only transiently in vaginal secretions. Although viral RNA during primary infection was cleared from blood plasma and urine within 10 days, viral RNA was detectable in saliva and seminal fluids until the end of the study, three weeks after the disappearance of viral RNA from the blood. Zika RNA was also identified in tissues, including the brain and male and female reproductive tissues, during early and late stages of infection.

The control of primary Zika virus infection in the blood was correlated with rapid innate and adaptive immune responses. Re-infection of six animals 45 days after primary infection with a heterologous strain of the virus resulted in complete protection, which suggested that primary Zika virus infection elicited protective immunity.

“We found, initially, that the virus replicated very rapidly and was cleared from the blood in most animals within ten days,” said senior author Dr. James B. Whitney, assistant professor of medicine at Beth Israel Deaconess Medical Center. “Nevertheless, we observed viral shedding in other bodily fluids such as spinal fluid, saliva, urine, and semen up to three weeks after the initial infection was already cleared. Of particular concern, we saw extraordinarily high levels of Zika virus in the brain of some of the animals – the cerebellum, specifically – soon after infection. Only one in five adults have noticeable symptoms of infection. However, if our data translate to humans, there may be need for enhanced clinical vigilance for any persons presenting with unusual neurological symptoms, and they should be tested for Zika infection.”

“We found that male-to-female transmission might be easier, while female-to-male may be less likely,” said Dr. Whitney. “Nonetheless, the high levels of Zika we observed in the uterus underscore the danger to a developing fetus.”

Related Links:
Beth Israel Deaconess Medical Center

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A massive study has identified new biomarkers for renal cancer subtypes, improving diagnosis and treatment (Photo courtesy of Jessica Johnson)

Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes

Renal cell carcinomas (RCCs) are notably diverse, encompassing over 20 distinct subtypes and generally categorized into clear cell and non-clear cell types; around 20% of all RCCs fall into the non-clear... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more